Johnson & Johnson (JNJ) stock news · P/E 31, rev $94.19B
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
This JNJ news page leads with what Johnson & Johnson filed — not a scraped headline mill.
No cached 8-K sentence for JNJ yet. We will not pad this page with generic market recap.
Latest reported JNJ revenue for 2025-12-28 was $94.19B. Net income was $26.80B. Revenue was up 6.0% from 2024-12-29 to 2025-12-28. JNJ currently screens at market cap $375.37B and trailing P/E 30.6.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the JNJ stock page; for the tape open the quote page.
JNJ stock news FAQ
What are JNJ's latest revenue and net income?
Latest cached Johnson & Johnson (JNJ) revenue for Dec 28, 2025 was $94.19B. Net income was $26.80B. Statements: https://lician.com/financials/jnj
How did JNJ revenue change from the prior cached period?
Cached Johnson & Johnson (JNJ) revenue was up 6.0% from $88.82B (Dec 29, 2024) to $94.19B (Dec 28, 2025). Statements: https://lician.com/financials/jnj
What is JNJ's P/E ratio?
Johnson & Johnson (JNJ) trailing P/E is 30.6 on the latest cached fundamentals snapshot.
What is JNJ's market cap?
Johnson & Johnson (JNJ) market cap is $375.37B on the latest cached fundamentals snapshot.
What kind of company is JNJ?
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US.
Where is JNJ stock news listed?
Cached stock news for Johnson & Johnson (JNJ) is listed at https://lician.com/news/jnj. Filings: https://lician.com/sec/jnj
Not investment advice.